This 2-day, 8-hour, virtual-live workshop is designed for providers new to the field of addiction medicine in settings such as primary care, emergency care, and behavioral health, who see patients at risk for or with substance use disorders (SUDs).

This 1-hour, live webinar will summarize recommendations on medication management for stimulant use disorder from ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder. The webinar will include discussion of a case scenario and a question-and-answer session.

This 1-hour online webinar will summarize recommendations on behavioral treatments for stimulant use disorder from ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder. The webinar will include discussion of a case scenario and a question-and-answer session.

This 1-hour, live webinar will summarize recommendations on management of stimulant intoxication and withdrawal from ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder. The webinar will include discussion of a case scenario and a question-and-answer session.

This 1-hour, online webinar will summarize recommendations on stimulant use prevention and harm reduction from ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder. The webinar will include discussion of a case scenario and a question-and-answer session.

This one-hour, on-demand, journal article-based activity that reviews a recent study that examines death certificate data to assess the staggering increase in overdose death rates among Black and Indigenous women in Wisconsin from 2018 to 2020. According to the study, Wisconsin overdose deaths in this population increased 11-fold from 2000 to 2020, with over 1,200 deaths in 2020.

This one-hour, on-demand, journal article-based activity compares characteristics of participants who reported using xylazine to those who reported not using xylazine in the past 12 months. Data from the National HIV Behavioral Surveillance Survey among persons who inject drugs (PWIDs) in Philadelphia was reviewed to better identify individuals at risk and inform patients and clinicians about xylazine risk factors.

This 2.5-hour activity provides five interactive patient cases on advanced knowledge and skills in the use of buprenorphine, focusing on best practices and emerging evidence in initiation, management, and dosing strategies.

This 90-minute, online course provides advanced knowledge and skills in the use of buprenorphine, focusing on best practices and emerging evidence in initiation, management, and dosing strategies.

This 16-hour, on-demand course is the essential primer for physicians preparing for the addiction medicine examination and also serves to increase other healthcare professionals' knowledge of addiction.